The National Medicines Institute found that the product does not meet quality requirements due to incorrect mean content of fluticasone and salmeterol per dose and lack of dose uniformity between containers. Potential effects: lack of treatment efficacy, worsening of asthma or COPD symptoms.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
FAQ